Stockscreener 앱 받기
75.66
0.58%
0.44
시간 외 거래:
75.66
전일 마감가:
$75.22
열려 있는:
$75.07
하루 거래량:
1.05M
Relative Volume:
0.92
시가총액:
$13.12B
수익:
$8.31B
순이익/손실:
$379.00M
주가수익비율:
35.03
EPS:
2.16
순현금흐름:
$385.00M
1주 성능:
+5.79%
1개월 성능:
+5.83%
6개월 성능:
+6.35%
1년 성능:
+11.43%
1일 변동 폭
$74.68
$76.17
1주일 범위
$70.06
$76.17
52주 변동 폭
$60.70
$85.92
Solventum Corp Stock (SOLV) Company Profile
명칭
Solventum Corp
전화
651-733-1110
주소
C/O 3M COMPANY, ST. PAUL
SOLV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
75.66 | 13.05B | 8.31B | 379.00M | 385.00M | 2.16 |
|
ISRG
Intuitive Surgical Inc
|
549.51 | 200.47B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
193.04 | 55.33B | 21.84B | 1.68B | 2.67B | 5.8322 |
|
ALC
Alcon Inc
|
77.65 | 38.61B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
244.46 | 36.80B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
261.36 | 19.18B | 2.96B | 487.70M | 344.00M | 6.6758 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-01 | 개시 | UBS | Neutral |
| 2025-09-11 | 개시 | Jefferies | Hold |
| 2025-07-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2025-07-01 | 업그레이드 | Argus | Hold → Buy |
| 2025-06-06 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2025-05-19 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2024-12-04 | 개시 | Mizuho | Neutral |
| 2024-10-08 | 개시 | Stifel | Buy |
| 2024-10-07 | 개시 | Piper Sandler | Neutral |
| 2024-09-26 | 개시 | Wolfe Research | Peer Perform |
| 2024-09-05 | 개시 | BTIG Research | Neutral |
| 2024-06-24 | 개시 | Argus | Hold |
| 2024-05-30 | 개시 | Goldman | Sell |
| 2024-05-10 | 개시 | BofA Securities | Neutral |
| 2024-04-10 | 개시 | Morgan Stanley | Equal-Weight |
| 2024-04-08 | 개시 | Wells Fargo | Equal Weight |
| 2024-04-02 | 개시 | Edward Jones | Hold |
모두보기
Solventum Corp 주식(SOLV)의 최신 뉴스
Can Solventum Corporation stock rebound after recent weaknessEarnings Risk Report & High Yield Stock Recommendations - newser.com
Why Solventum Corporation stock stays resilientExit Point & Fast Gaining Stock Strategy Reports - newser.com
Can trapped investors hope for a rebound in Solventum CorporationTreasury Yields & Proven Capital Preservation Tips - newser.com
Is Solventum Corporation stock attractive for growth fundsMarket Weekly Review & Free High Accuracy Swing Entry Alerts - newser.com
Is Solventum Corporation stock inflation resilientPortfolio Growth Summary & Weekly Sector Rotation Insights - newser.com
Will Solventum Corporation benefit from macro trendsGlobal Markets & Weekly Return Optimization Alerts - newser.com
Solventum (SOLV) Is Up 5.8% After Raising Earnings Outlook on Strong Q3 Results - simplywall.st
Can Solventum Corporation stock resist broad market declinesJuly 2025 Selloffs & Short-Term High Return Ideas - newser.com
Solventum (SOLV) Is Up 5.8% After Q3 Profit Surges and Full-Year Outlook Raised—Has the Bull Case Changed? - Yahoo Finance
Solventum : Shareholder Letter Q3 2025 - MarketScreener
Why Solventum Corporation stock stays on top picksTrade Entry Summary & Precise Buy Zone Identification - newser.com
How to escape a deep drawdown in Solventum CorporationPortfolio Update Report & Reliable Price Breakout Alerts - newser.com
Solventum Stock: Analyst Estimates & Ratings - Barchart.com
Ranking Solventum Corporation among high performing stocks via toolsJuly 2025 Sentiment & Community Verified Trade Alerts - newser.com
A Look at Solventum's Valuation Following Upbeat Q3 Earnings and Raised 2025 Outlook - simplywall.st
5 Must-Read Analyst Questions From Solventum’s Q3 Earnings Call - Markets Financial Content
Transcript : Solventum Corporation Presents at Stifel 2025 Healthcare Conference, Nov-12-2025 11 - MarketScreener
Solventum (SOLV) Upgraded to Strong Buy: What Does It Mean for the Stock? - MSN
Is Solventum a Bargain After Recent Innovation and Partnerships Drive 9% Price Jump? - Yahoo Finance
Certain Common Stock of Solventum Corporation are subject to a Lock-Up Agreement Ending on 12-NOV-2025. - MarketScreener
Solventum: A Mixed Q3 Provides Further Support For Our Neutral Stance (NYSE:SOLV) - Seeking Alpha
UBS Maintains Solventum (SOLV) Neutral Recommendation - Nasdaq
SOLV: UBS Raises Price Target Amid Neutral Rating Stance | SOLV Stock News - GuruFocus
UBS Adjusts Price Target on Solventum to $79 From $77, Maintains Neutral Rating - MarketScreener
Cautious Outlook on Solventum Corporation Amid Cost-Saving Initiatives and Tariff Concerns - TipRanks
Solventum Lifts Outlook After Topping Earnings Expectations - Finimize
Solventum’s Earnings Call Highlights Growth and Optimism - The Globe and Mail
Solventum : Earnings Webcast Q3 2025 - MarketScreener
Solventum Corp (SOLV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.53%
1.64%
자본화:
|
볼륨(24시간):